Verus Financial Partners’s Precigen PGEN Stock Holding History

Verus Financial Partners’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-10,400	Closed	-$36K	–	161
2020 Q3	$36K	Buy	+10,400	New	+$49.4K	0.01%	170

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Verus Financial Partners's PGEN Position: Q4 2020 in Review

Verus Financial Partners sold out of Precigen (PGEN) in Q4 2020, closing a stake of 10,400 shares — an estimated $36K sold.

Verus Financial Partners first reported a position in PGEN in Q3 2020 and held it in 1 quarter. The position peaked at $36K in Q3 2020. 151 funds tracked by Wall St. Rank hold PGEN as of Q4 2020.

Verus Financial Partners reported no remaining Precigen position as of Q4 2020 after selling out during the quarter.
Verus Financial Partners sold 10,400 Precigen shares in Q4 2020, an estimated $36K.
Verus Financial Partners first reported a position in Precigen in Q3 2020 and held it in 1 quarter.
Verus Financial Partners's Precigen position peaked at $36K in Q3 2020.
151 funds tracked by Wall St. Rank held Precigen as of Q4 2020.

Based on Verus Financial Partners's 13F filing for Q4 2020, filed 10 Feb 2021.